AI-powered search
AI-powered search

On-Demand CME Videos

The Many Shades of Plaque Psoriasis: Considerations for Treating Skin of Color


This activity was recorded at the Fall Clinical Dermatology Conference 2023. 

The Many Shades of Plaque Psoriasis: Considerations for Treating Skin of Color

This activity is supported by educational grants from Bristol Myers Squibb and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.


In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

December 5, 2023

Expiration Date:

December 31, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Highlight the key different clinical presentations of plaque psoriasis in skin of color (SOC)

  • Review the unique treatment goals in patients with SOC that have psoriasis

  • Classify the role of novel targeted agents for the management of plaque psoriasis in SOC

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Andrew Alexis, MD, MPH

Vice-Chair for Diversity and Inclusion, Dept. of Dermatology
Professor of Clinical Dermatology 
Weill Cornell Medicine
New York, NY

Mona Shahriari, MD

Dermatologist, Yale University School of Medicine
Central CT Dermatology
Cromwell, CT

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Andrew F. Alexis, MD, MPH

Grant/Research Support: BMS, LEO, Novartis, Almirall

Consultant: Leo, Galderma, Pfizer, Sanofi- Regeneron

Speakers’ Bureau or Honoraria: Regeneron, SANOFI-Genzyme, Pfizer, BMS

Mona Shahriari, MD

Grant/Research Support: AbbVie, Dermira, Cara, Dermavant, Novartis, Union

Consultant: Abbvie, BMS, Dermavant, Leo, Lilly, Sanofi, Regeneron, UCB

Speakers’ Bureau or Honoraria: Abbvie, BMS, Lilly, Leo, Janssen, Dermavant

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved